PubRank

Adelino F Leite-Moreira

Author PubWeight™ 87.30‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur Heart J 2007 10.38
2 Attenuation of toll-like receptor 2-mediated innate immune response in patients with alcoholic chronic liver disease. Liver Int 2010 2.20
3 Low myocardial protein kinase G activity in heart failure with preserved ejection fraction. Circulation 2012 2.14
4 Hypophosphorylation of the Stiff N2B titin isoform raises cardiomyocyte resting tension in failing human myocardium. Circ Res 2009 1.99
5 In utero meconium exposure increases spinal cord necrosis in a rat model of myelomeningocele. J Pediatr Surg 2002 1.80
6 Diabetic cardiomyopathy: understanding the molecular and cellular basis to progress in diagnosis and treatment. Heart Fail Rev 2012 1.61
7 Meconium dependence of bowel damage in gastroschisis. J Pediatr Surg 2002 1.50
8 Cardiovascular endothelins: essential regulators of cardiovascular homeostasis. Pharmacol Ther 2006 1.42
9 Intraventricular pressure gradients throughout the cardiac cycle: effects of ischaemia and modulation by afterload. Exp Physiol 2012 1.41
10 Apelin decreases myocardial injury and improves right ventricular function in monocrotaline-induced pulmonary hypertension. Am J Physiol Heart Circ Physiol 2009 1.26
11 Diabetes mellitus worsens diastolic left ventricular dysfunction in aortic stenosis through altered myocardial structure and cardiomyocyte stiffness. Circulation 2011 1.22
12 Ghrelin, des-acyl ghrelin and obestatin: three pieces of the same puzzle. Peptides 2008 1.16
13 Myocardial titin hypophosphorylation importantly contributes to heart failure with preserved ejection fraction in a rat metabolic risk model. Circ Heart Fail 2013 1.14
14 Effect of ivabradine on heart failure with preserved ejection fraction. J Am Coll Cardiol 2013 1.08
15 Distinct mechanisms for diastolic dysfunction in diabetes mellitus and chronic pressure-overload. Basic Res Cardiol 2011 1.05
16 Functional polymorphisms of Toll-like receptors 2 and 4 alter the risk for colorectal carcinoma in Europeans. Dig Liver Dis 2012 1.01
17 Increased expression of toll-like receptors (TLR) 2, 4 and 5 in gastric dysplasia. Pathol Oncol Res 2011 0.96
18 The apelinergic system: the role played in human physiology and pathology and potential therapeutic applications. Arq Bras Cardiol 2008 0.96
19 Time course and mechanisms of left ventricular systolic and diastolic dysfunction in monocrotaline-induced pulmonary hypertension. Basic Res Cardiol 2009 0.96
20 Targeting myocardial remodelling to develop novel therapies for heart failure: a position paper from the Working Group on Myocardial Function of the European Society of Cardiology. Eur J Heart Fail 2014 0.95
21 Apelin: a novel neurohumoral modulator of the cardiovascular system. Pathophysiologic importance and potential use as a therapeutic target. Rev Port Cardiol 2005 0.95
22 New pathways of the renin-angiotensin system: the role of ACE2 in cardiovascular pathophysiology and therapy. Expert Opin Ther Targets 2010 0.94
23 Physiological, pathological and potential therapeutic roles of adipokines. Drug Discov Today 2012 0.94
24 Attenuation of the cardiovascular and metabolic complications of obesity in CD14 knockout mice. Life Sci 2008 0.94
25 Towards a re-definition of 'cardiac hypertrophy' through a rational characterization of left ventricular phenotypes: a position paper of the Working Group 'Myocardial Function' of the ESC. Eur J Heart Fail 2011 0.92
26 Increased hepatic expression of TLR2 and TLR4 in the hepatic inflammation-fibrosis-carcinoma sequence. Innate Immun 2012 0.92
27 Helicobacter pylori induces increased expression of Toll-like receptors and decreased Toll-interacting protein in gastric mucosa that persists throughout gastric carcinogenesis. Helicobacter 2012 0.91
28 Cardiac venous arterialization in acute myocardial infarction: how great is the benefit? Interact Cardiovasc Thorac Surg 2012 0.88
29 Acute changes of biventricular gene expression in volume and right ventricular pressure overload. Life Sci 2005 0.88
30 Current pathophysiological concepts and management of pulmonary hypertension. Int J Cardiol 2012 0.86
31 Pivotal role of microRNAs in cardiac physiology and heart failure. Drug Discov Today 2013 0.85
32 M-mode and Doppler echocardiographic reference values for male New Zealand white rabbits. Am J Vet Res 2006 0.84
33 Cystic adenomatoid malformations are induced by localized FGF10 overexpression in fetal rat lung. Am J Respir Cell Mol Biol 2008 0.84
34 Endogenous production of ghrelin and beneficial effects of its exogenous administration in monocrotaline-induced pulmonary hypertension. Am J Physiol Heart Circ Physiol 2004 0.84
35 Targeted gene transfer to fetal rat lung interstitium by ultrasound-guided intrapulmonary injection. Mol Ther 2007 0.84
36 Hypertension and angiogenesis in the aging kidney: a review. Arch Gerontol Geriatr 2010 0.84
37 Acute neurohumoral modulation of diastolic function. Peptides 2008 0.83
38 The apelinergic system: a promising therapeutic target. Expert Opin Ther Targets 2010 0.83
39 Thymulin inhibits monocrotaline-induced pulmonary hypertension modulating interleukin-6 expression and suppressing p38 pathway. Endocrinology 2008 0.83
40 Myocardial dysfunction and neurohumoral activation without remodeling in left ventricle of monocrotaline-induced pulmonary hypertensive rats. Am J Physiol Heart Circ Physiol 2006 0.83
41 Myocardial effects of endothelin-1. Rev Port Cardiol 2008 0.83
42 Decreased Toll-interacting protein and peroxisome proliferator-activated receptor γ are associated with increased expression of Toll-like receptors in colon carcinogenesis. J Clin Pathol 2012 0.82
43 Intermedin elicits a negative inotropic effect in rat papillary muscles mediated by endothelial-derived nitric oxide. Am J Physiol Heart Circ Physiol 2012 0.82
44 Toll-like receptors as therapeutic targets in gastrointestinal diseases. Expert Opin Ther Targets 2010 0.82
45 Echocardiographic evaluation including tissue Doppler imaging in New Zealand white rabbits sedated with ketamine and midazolam. Vet J 2008 0.82
46 METformin in DIastolic Dysfunction of MEtabolic syndrome (MET-DIME) trial: rationale and study design : MET-DIME trial. Cardiovasc Drugs Ther 2014 0.82
47 Therapeutic potential of neuregulin-1 in cardiovascular disease. Drug Discov Today 2013 0.82
48 Cardiovascular actions of adiponectin: pathophysiologic implications. Rev Port Cardiol 2008 0.81
49 Adiponectin levels are elevated in patients with pulmonary arterial hypertension. Clin Cardiol 2013 0.81
50 Effects of adrenomedullin on systolic and diastolic myocardial function. Peptides 2008 0.81
51 Ghrelin expression in human and rat fetal lungs and the effect of ghrelin administration in nitrofen-induced congenital diaphragmatic hernia. Pediatr Res 2006 0.81
52 Titin mutations: the fall of Goliath. Heart Fail Rev 2015 0.81
53 Concomitant unipolar radiofrequency ablation of nonparoxysmal atrial fibrillation in rheumatic and degenerative valve disease. J Card Surg 2014 0.81
54 N-terminal-pro-B type natriuretic peptide as a useful tool to evaluate pulmonary hypertension and cardiac function in CDH infants. Neonatology 2007 0.80
55 A Western-type diet attenuates pulmonary hypertension with heart failure and cardiac cachexia in rats. J Nutr 2011 0.80
56 Inotropic and lusitropic effects of ghrelin and their modulation by the endocardial endothelium, NO, prostaglandins, GHS-R1a and KCa channels. Peptides 2006 0.80
57 Left intraventricular diastolic and systolic pressure gradients. Exp Biol Med (Maywood) 2011 0.79
58 Antenatal vitamin A administration attenuates lung hypoplasia by interfering with early instead of late determinants of lung underdevelopment in congenital diaphragmatic hernia. J Pediatr Surg 2005 0.79
59 Impaired response to ET(B) receptor stimulation in heart failure: functional evidence of endocardial endothelial dysfunction? Exp Biol Med (Maywood) 2006 0.79
60 Local modulation of the natriuretic peptide system in the rat remnant kidney. Nephrol Dial Transplant 2009 0.79
61 Central nervous system circuits modified in heart failure: pathophysiology and therapeutic implications. Heart Fail Rev 2014 0.79
62 Myocardial remote ischemic preconditioning: from pathophysiology to clinical application. Rev Port Cardiol 2013 0.79
63 Angiotensin-(1-7) modulates angiotensin II-induced vasoconstriction in human mammary artery. Cardiovasc Drugs Ther 2014 0.79
64 Fetal heart development in the nitrofen-induced CDH rat model: the role of mechanical and nonmechanical factors. J Pediatr Surg 2003 0.78
65 [Cardiorenal syndrome and its pathophysiological implications]. Rev Port Cardiol 2010 0.78
66 Reverse myocardial effects of intermedin in pressure-overloaded hearts: role of endothelial nitric oxide synthase activity. J Physiol 2012 0.78
67 Endothelin ETA receptors and endothelium partially mediate the positive inotropic and lusitropic effects of angiotensin II. Eur J Pharmacol 2006 0.78
68 Cardiac dysfunction in HgCl2-induced nephrotic syndrome. Exp Biol Med (Maywood) 2010 0.78
69 Angiotensin II-induced increase in myocardial distensibility and its modulation by the endocardial endothelium in the rabbit heart. Exp Physiol 2009 0.77
70 Remote cardiac ischemic conditioning: underlying mechanisms and clinical applications. Rev Port Cir Cardiotorac Vasc 2014 0.77
71 Urotensin II acutely increases myocardial length and distensibility: potential implications for diastolic function and ventricular remodeling. Naunyn Schmiedebergs Arch Pharmacol 2007 0.77
72 Acute modulation of myocardial function by angiotensin 1-7. Peptides 2009 0.77
73 Pathophysiology of chronic heart failure. Rev Port Cardiol 2009 0.76
74 Modulation of the myocardial effects of selective ETB receptor stimulation and its implications for heart failure. Rev Port Cardiol 2005 0.76
75 Endothelin-converting enzyme inhibitors: their application in cardiovascular diseases. Rev Port Cardiol 2008 0.76
76 A high-calorie diet attenuates cachexia and adipose tissue inflammation in monocrotaline-induced pulmonary hypertensive rats. Rev Port Cardiol 2010 0.76
77 Contractile effects of Ghrelin and expression of its receptor GHS-R1a in normal and hypertrophic myocardium. Rev Port Cardiol 2005 0.76
78 The effects of angiotensin II signaling pathway in the systolic response to acute stretch in the normal and ischemic myocardium. Peptides 2013 0.76
79 [Calcium kinetics in the progression of heart failure]. Rev Port Cardiol 2004 0.76
80 Role of Toll-like receptor impairment in cirrhosis infection risk: are we making progress? Liver Int 2010 0.76
81 Haemodynamic and neuroendocrine effects of tezosentan in chronic experimental pulmonary hypertension. Intensive Care Med 2012 0.76
82 The role of titin in the modulation of cardiac function and its pathophysiological implications. Arq Bras Cardiol 2011 0.76
83 Obligatory role of the endocardial endothelium in the increase of myocardial distensibility induced by endothelin-1. Exp Biol Med (Maywood) 2006 0.76
84 Remote myocardium gene expression after 30 and 120 min of ischaemia in the rat. Exp Physiol 2006 0.75
85 Ghrelin reverses molecular, structural and hemodynamic alterations of the right ventricle in pulmonary hypertension. Rev Port Cardiol 2006 0.75
86 Physiologic basis and pathophysiologic implications of the diastolic properties of the cardiac muscle. J Biomed Biotechnol 2010 0.75
87 Beat-to-beat modulation of right and left ventricular positive dP/dt by afterload. Implications for the evaluation of inotropy. Acta Cardiol 2003 0.75
88 Activation profile of pro-inflammatory cytokines in acute cardiac overload. Rev Port Cardiol 2005 0.75
89 Genetic testing strategies for the diagnosis of hypertrophic cardiomyopathy. Rev Port Cardiol 2011 0.75
90 [Nitric oxide in the physiopathology of myocardial dysfunction in heart failure]. Rev Port Cardiol 2004 0.75
91 Stem cells and myocardial regeneration. Rev Port Cardiol 2004 0.75
92 Innate immune receptor activation in viral myocarditis: pathophysiologic implications. Rev Port Cardiol 2010 0.75
93 Radiofrequency ablation of atrial fibrillation during concomitant cardiac surgery. Rev Port Cir Cardiotorac Vasc 2015 0.75
94 Effects of diabetes mellitus, pressure-overload and their association on myocardial structure and function. Am J Hypertens 2009 0.75
95 Meeting highlights from the 2013 European Society of Cardiology Heart Failure Association Winter Meeting on Translational Heart Failure Research. Eur J Heart Fail 2013 0.75
96 Negative inotropic effect of selective AT2 receptor stimulation and its modulation by the endocardial endothelium. Eur J Pharmacol 2007 0.75
97 Ventricular BNP gene expression in acute cardiac overload. Rev Port Cardiol 2004 0.75
98 [Heart failure]. Rev Port Cardiol 2004 0.75
99 Prospective randomised comparison of Marsh and Schnider pharmacokinetic models for propofol during induction of anaesthesia in elective cardiac surgery. Eur J Anaesthesiol 2012 0.75
100 Pathophysiology of infantile pulmonary arterial hypertension induced by monocrotaline. Pediatr Cardiol 2015 0.75
101 [Renin-angiotensin system and its role in cardiovascular physiopathology and therapy]. Rev Port Cardiol 2004 0.75
102 Direct downregulation of Toll-like receptors by anti-IL-2 alpha chain-receptor antibody in cadaver kidney transplant recipients. Transplantation 2009 0.75
103 Agreement between echocardiographic techniques in assessment of the left ventricular myocardial performance index in rabbits. Am J Vet Res 2009 0.75
104 Understanding the molecular and cellular changes behind aortic valve stenosis. Curr Pharm Biotechnol 2012 0.75